Kantoff PW - Search Results

1

Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.

Pomerantz MM, Werner L, Xie W, Regan MM, Lee GS, Sun T, Evan C, Petrozziello G, Nakabayashi M, Oh WK, Kantoff PW, Freedman ML. Pomerantz MM, et al. Among authors: kantoff pw. Cancer Prev Res (Phila). 2011 May;4(5):719-28. doi: 10.1158/1940-6207.CAPR-10-0292. Epub 2011 Mar 2. Cancer Prev Res (Phila). 2011. PMID: 21367958 Free PMC article.

2

Detection of circulating tumor cells in men with localized prostate cancer.

Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Seiden MV, et al. Among authors: kantoff pw. J Clin Oncol. 1994 Dec;12(12):2634-9. doi: 10.1200/JCO.1994.12.12.2634. J Clin Oncol. 1994. PMID: 7527455

3

Two differentially expressed genes in normal human prostate tissue and in carcinoma.

Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB. Wang FL, et al. Among authors: kantoff pw. Cancer Res. 1996 Aug 15;56(16):3634-7. Cancer Res. 1996. PMID: 8705997

4

The prostate specific antigen. Its use as a tumor marker for prostate cancer.

Kantoff PW, Talcott JA. Kantoff PW, et al. Hematol Oncol Clin North Am. 1994 Jun;8(3):555-72. Hematol Oncol Clin North Am. 1994. PMID: 8707772 Review.

5

Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinoma.

Kibel AS, Krithivas K, Shamel LB, Kantoff PW, DeWolf WC. Kibel AS, et al. Among authors: kantoff pw. Urology. 1996 Nov;48(5):741-6. doi: 10.1016/S0090-4295(96)00235-X. Urology. 1996. PMID: 8911518

6

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.

Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stampfer MJ. Kantoff PW, et al. Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):189-92. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9138662

7

The androgen receptor gene GGN microsatellite and prostate cancer risk.

Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW. Platz EA, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):379-84. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9610786 Clinical Trial.

8

Management of hormone refractory prostate cancer: current standards and future prospects.

Oh WK, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. J Urol. 1998 Oct;160(4):1220-9. J Urol. 1998. PMID: 9751323 Review.

9

Debrisoquine hydroxylase (CYP2D6) and prostate cancer.

Febbo PG, Kantoff PW, Giovannucci E, Brown M, Chang G, Hennekens CH, Stampfer M. Febbo PG, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1075-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9865424

10

Prognostic indicators in hormone refractory prostate cancer.

George DJ, Kantoff PW. George DJ, et al. Among authors: kantoff pw. Urol Clin North Am. 1999 May;26(2):303-10, viii. doi: 10.1016/s0094-0143(05)70070-7. Urol Clin North Am. 1999. PMID: 10361553 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters